Back to calendar
REGENXBIO Inc. (RGNX) Earnings
RGNX reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026
Q2 2026
Est. EPS: $-1.08
Actual EPS: $0.43
EPS surprise: 446.19%
Company overview
Market Cap$723.0M
PriceUSD 11.07
EPS (TTM)-5.59
52-week high16.19
52-week low5.46
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees371